Screening methods of cervical cancer- A comparative analysis

Completed

Conditions: Malignant neoplasm of cervix uteri, unspecified,

Registration Number: CTRI/2020/08/027023

Lead Sponsor: Gajra Raja Medical College

Brief Summary: 500 patients who meet the inclusion criteria are chosen. After taking proper history and consent, the women is subjected to cervical cytology. The cytology is studied and reported by Bethesda system. Then the women is subjected to visual inspection the acetic acid. If sharp well defined acetowhite areas touching squamocoloumnar junction are found, they are considered positive and subjected to histopathology. Then a comparative analysis of cervical cytology, visual inspection with acetic acid and histopathology is done.

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Female

Target Recruitment: 500

Inclusion Criteria

All sexually active women and women in reproductive age group with recurrent episodes of white discharge, postcoital bleeding and intermenstrual bleeding.

Exclusion Criteria

Women who refused to give consent and known cases of cervical carcinoma, pregnant women, women with active vaginal bleeding.

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
For women who are devoid of any screening test, VIA based screenng will be a good screening tool.	At the end of the study (i.e, 1 year)

Secondary Outcome Measures

Name	Time	Method
To calculate the sensitivity and specificity of VIA screeing of carcinoma cervix.	At the end of the study (i.e, 1 year)

Trial Locations

Locations (1): Gajra Raja Medical College
🇮🇳
Gwalior, MADHYA PRADESH, India
Gajra Raja Medical College
🇮🇳Gwalior, MADHYA PRADESH, India
Japhia David
Principal investigator
8667367291
japhia29@gmail.com